Are Republicans Afraid to Decriminalize Marijuana? 

 

The U.S. House of Representatives’ long-awaited vote to decriminalize marijuana on the federal level has been postponed until after Election Day, drawing criticism from pot advocates.

The House was scheduled to vote  in mid September on the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which would remove cannabis from the Controlled Substances Act, expunge some criminal records, and create funding for people and communities impacted by the War on Drugs. 

 

Some progressive Democrats expressed frustration with the delay.

“I feel like the impulse to delay the expungement of people’s records is a fear-based response to [Senate Majority Leader] Mitch McConnell [R-KY] and the Republican Party,” Rep. Alexandria Ocasio-Cortez, D-NY, said. “And I personally don’t think that we should be governing that way. I don’t think that when Democrats have power, like a House majority, that we should be drafting our agenda based out of fear of Republicans.” 

 

But moderate Democrats expressed concerns about voting on the measure before wrapping up coronavirus legislation, according to The Hill.

House Majority Leader Steny Hoyer, D-MD, who removed the MORE Act from the schedule, said Democratic leaders remain “committed” to voting on the legislation before the end of the year.

“Right now, the House is focused relentlessly on securing agreement to stave off a damaging government shutdown and continuing to do its job addressing the COVID-19 pandemic,” Hoyer told The Hill. “Later this autumn, the House will pass the MORE Act with strong support as yet another crucial step toward making our justice system fair for all Americans.”

Justin Strekal, political director of NORML, said in a statement that the “delay does not change the fact that the overwhelming majority of voters support ending the federal prohibition of cannabis, including majorities of Democrats, Independents, and Republicans.”
 

  • CannaAid and Peak: Something new for everyone.

Recent Articles

As a lifelong stoner, feminist, and teacher, Luna Stower does know how intersectional plant medicine can be.
“Whenever somebody sees ‘Sales Guru’ on my card, they ask how you become one,” he says. “I tell them that you spend your life in sales, and you go to Nepal to climb the Himalayas to meet the real gurus. You get the wisdom from them, then you bring it back down and apply it to your life.”
Cryptocurrency is taking the world by storm. It’s been over 15 years since the launch of Bitcoin, and although it’s more popular than ever before, it’s not the only form of crypto available today.
We know breaking up is hard to do, but sometimes the thrill is gone, and it’s time to move on. It doesn’t matter how long a brand’s been riding with you or how tight you are with the sales rep. If the product doesn’t perform, or worse, if the brand loses touch with the culture, it’s dead weight. And dead weight doesn’t just slow you down; it can drown you.
At HQ, we don’t shy away from controversy, but we also don’t exist to tear down legitimate players in the industry. We chose instead to invite both perspectives to weigh in.
Ali Bianco wants to elevate the cannabis world one pink pre-roll at a time. Since high school, she’s been sick of the stigma around weed and the idea that stoners are lazy and unkempt. Inspired by Blake Lively’s character smoking pink cigarettes in the 2011 film Hick, Ali decided to “make weed something beautiful” with a feminist kick.
In the early days, we bought flower based on two metrics: THC percentage and the vague promise of either indica or sativa. It was like ordering wine based on alcohol content and whether the label showed a beach or a mountain. We’ve come a long way.
I've witnessed firsthand how patient advocacy can profoundly change healthcare and people's lives. Today, I'm honored to lead ASA once again, as we intensify efforts to ensure medical cannabis reaches all patients who need it, fully integrated into our nation's healthcare system.